Health

FDA approves Roches Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer

Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase…

3 months ago

Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD

October 02, 2025 10:00 ET  | Source: Cirrus Therapeutics, Inc. Cirrus’ lead program is a novel AAV gene therapy designed…

3 months ago

24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Natures Toughest Fiber

DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial…

3 months ago

PharmAla Completes Shipment of LaNeo MDMA to Johns Hopkins

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology…

3 months ago

EssilorLuxottica completes acquisition of Optegra

EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the acquisition…

3 months ago

The Facial Pain Association (FPA) Highlights Trigeminal Neuralgia and the Facial Pain Community during Facial Pain Awareness Month

SUWANEE, Ga., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Throughout October, the Facial Pain Association (FPA) commemorates Facial Pain Awareness Month…

3 months ago

Cirtec Medical Appoints Steven Chevillotte to its Board of Directors

October 01, 2025 13:01 ET  | Source: Cirtec Medical BROOKLYN PARK, Minn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical,…

3 months ago

YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

September 30, 2025 17:25 ET  | Source: YD Bio Limited TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited…

3 months ago

The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck…

3 months ago

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 30, 2025 16:24 ET  | Source: Pyxis Oncology BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq:…

3 months ago